ERBB2 and breast carcinoma: Cases with high RAF1 mRNA expression had a lower distant metastasis-free survival in HER2 (-) breast cancers (p = .011), while HER2(+) breast cancer was not related to the distal metastasis-free survival (p = .066) (Figure 1B).